Sankaijo

Manufacturer
Sato Pharmaceutical Co., Ltd.
Effective date
2023-11-29
Label type
HUMAN OTC DRUG LABEL
Version
11
Source
full-release
Hydrated at
2026-06-01 00:02:54

Label at a glance#

ProductSankaijo
Active ingredientDOCUSATE SODIUM, SENNOSIDES
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients (in each tablet)
Docusate sodium 8.33mg
Sennosides 1.36mg

OTC - PURPOSE SECTION

Purposes
Docusate sodium    Stool softener laxative
Sennosides    Stimulant laxative

INDICATIONS & USAGE SECTION

Uses
■for the relief of occasional constipation (irregularity)
■generally produces bowel movement in 6 to 12 hours

WARNINGS SECTION

Warnings

OTC - DO NOT USE SECTION

Do not use laxative products for a period longer than 1 week unless directed by a doctor

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have
■abdominal pain, nausea, or vomiting
■noticed a sudden change in bowel habits that persists over a period of 2 weeks

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before useif you are presently taking mineral oil

OTC - STOP USE SECTION

Stop use and ask a doctor if
■you have rectal bleeding or failure to have a bowel movement after use of a laxative (may indicate a serious condition)

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away.

GENERAL PRECAUTIONS SECTION

Frequent or prolonged use of this preparation may result in dependence on laxatives.

DOSAGE & ADMINISTRATION SECTION

Directions
adults and children 12 years and older  -  take 6 to 12 tablets once or twice a day
children 6 to under 12 years -  take 5 to 7 tablets once or twice a day
children 2 to under 6 years  -  take 3 to 5 tablets once or twice a day
children under 2 years -  consult a doctor
■once or twice daily, preferably morning and evening, when needed or as directed by a doctor
■start initial dosage with minimum dose, then adjust it to suit to bowel condition

OTHER SAFETY INFORMATION

Other information 
■each tablet contains calcium 5 mg

INACTIVE INGREDIENT SECTION

Inactive ingredients  caramel, carmellose calcium, cinnamon, dibasic calcium phosphate, FDandC Blue No. 2, fennel, hydroxypropyl methylcellulose, magnesium stearate, mentha oil, microcrystalline cellulose, moutan bark, pharbitis seed, polyoxyethylene (105) polyoxypropylene (5) glycol, silicon dioxide, simethicone, synthetic iron oxide, talc

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CartonCarton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1235252docusate sodium 8.33 MG / sennosides 1.36 MG Oral TabletPSN11
1235252docusate sodium 8.33 MG / sennosides, USP 1.36 MG Oral TabletSCD11
1235252DOSS Sodium 8.33 MG / sennosides, USP 1.36 MG Oral TabletSY11

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49873-404-01Sankaijo1 in 1 CARTONTABLET111
49873-404-01Sankaijo150 in 1 BOTTLETABLET15011

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49873-404SANKAIJO (DOCUSATE SODIUM, SENNOSIDES) TABLET [SATO PHARMACEUTICAL CO., LTD.]11Current NDC, Legacy NDC, 2 package rows20231130_83c0d52b-f7e2-40b0-a01b-1ccee78f8f1b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
docusate sodiumACTIVE INGREDIENTF05Q2T2JA06
SENNOSIDESACTIVE INGREDIENT3FYP5M0IJX6
docusateACTIVE MOIETYM7P27195AG6
SENNOSIDESACTIVE MOIETY3FYP5M0IJX6
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92J6
caramelINACTIVE INGREDIENTT9D99G2B1R6
CARBOXYMETHYLCELLULOSE CALCIUMINACTIVE INGREDIENTUTY7PDF93L6
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U6
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O6
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQK6
FENNELINACTIVE INGREDIENT557II4LLC36
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6756
HYPROMELLOSE 2910 (15000 MPA.S)INACTIVE INGREDIENT288VBX44JC6
IPOMOEA NIL SEEDINACTIVE INGREDIENTI85W45B4WB6
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I306
PAEONIA SUFFRUTICOSA ROOT BARKINACTIVE INGREDIENTBUG255FE7X6
PEG/PPG-105/5 COPOLYMERINACTIVE INGREDIENT52901V8XAR6
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU46
TALCINACTIVE INGREDIENT7SEV7J4R1U6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49873-40449873-404-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 30 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKTABLET / ORAL25 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
caramelCARAMELT9D99G2B1RSYRUP / ORAL207 mg/5mlExact identifier — unii+route
12 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / ORAL750 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET / ORAL8 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / ORAL1000 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
caramelCARAMELT9D99G2B1RSOLUTION / ORAL11 mgExact identifier — unii+route
12 equally ranked IID candidates
caramelCARAMELT9D99G2B1RSYRUP / ORAL207 mg/5mlExact identifier — unii+route
12 equally ranked IID candidates
caramelCARAMELT9D99G2B1RCAPSULE / ORALNAExact identifier — unii+route
12 equally ranked IID candidates
caramelCARAMELT9D99G2B1RSUSPENSION / ORAL111.12 mg/5mlExact identifier — unii+route
12 equally ranked IID candidates
caramelCARAMELT9D99G2B1RSUSPENSION / ORAL111.12 mg/5mlExact identifier — unii+route
12 equally ranked IID candidates
caramelCARAMELT9D99G2B1RGRANULE, FOR SUSPENSION / ORAL2.5 mg/5mlExact identifier — unii+route
12 equally ranked IID candidates
HYPROMELLOSE 2910 (15000 MPA.S)HYPROMELLOSE 2910 (15000 MPA.S)288VBX44JCTABLET / ORAL29 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE CALCIUMCARBOXYMETHYLCELLULOSE CALCIUMUTY7PDF93LTABLET / ORAL967 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
caramelCARAMELT9D99G2B1RGRANULE, FOR SUSPENSION / ORAL2.5 mg/5mlExact identifier — unii+route
12 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / ORAL1000 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKTABLET / ORAL25 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JTABLET / ORAL2240 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET / ORAL6184 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / ORAL750 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
caramelCARAMELT9D99G2B1RCAPSULE / ORALNAExact identifier — unii+route
12 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET / ORAL6184 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE CALCIUMCARBOXYMETHYLCELLULOSE CALCIUMUTY7PDF93LTABLET / ORAL967 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
caramelCARAMELT9D99G2B1RLIQUID / ORAL5.3 mgExact identifier — unii+route
12 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET / ORAL8 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
caramelCARAMELT9D99G2B1RSOLUTION / ORAL11 mgExact identifier — unii+route
12 equally ranked IID candidates
HYPROMELLOSE 2910 (15000 MPA.S)HYPROMELLOSE 2910 (15000 MPA.S)288VBX44JCTABLET / ORAL29 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSANHYDROUS DIBASIC CALCIUM PHOSPHATEL11K75P92JTABLET / ORAL2240 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
caramelCARAMELT9D99G2B1RLIQUID / ORAL5.3 mgExact identifier — unii+route
12 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SankaijoDOCUSATE SODIUM, SENNOSIDESSato Pharmaceutical Co., Ltd.83c0d52b-f7e2-40b0-a01b-1ccee78f8f1b2023-11-29WarningsExact identifier
ndc (package): 49873-404-01
ndc (product): 49873-404
ndc11 (package): 49873040401
spl id: 0b54b2d1-83e7-3a18-e063-6394a90a5b58
spl set id: 83c0d52b-f7e2-40b0-a01b-1ccee78f8f1b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.